1 The contribution of reactive nitrogen species to the development of airway hyperresponsiveness in a mouse model of allergic in¯ammation was investigated by the use of selective inhibitors of nitric oxide and superoxide formation. 2 Sensitized mice, repeatedly challenged with ovalbumin showed a signi®cant (P50.001, n=9) increase in airway responsiveness measured using whole body plethysmography. This hyperresponsiveness was accompanied by an in¯ux of eosinophils into the airway lumen and increased levels of ovalbumin-speci®c serum IgE. 3 Treatment of mice with the iNOS inhibitor 1400 W or the NADPH-oxidase inhibitor apocynin did not signi®cantly alter cellular in¯ux into the airway lumen nor serum ovalbumin speci®c IgE. In contrast, apocynin as well as 1400 W inhibited ovalbumin-induced airway hyperresponsiveness (P50.001 and P50.05 respectively, n=9). Furthermore, the airways of allergen challenged animals showed clear 3-nitrotyrosine staining, which was mainly located in eosinophils. Remarkably, treatment with apocynin or 1400 W did not alter 3-nitrotyrosine staining. 4 These data suggest that the development of airway hyperresponsiveness during the airway in¯ammation upon ovalbumin challenge is dependent on the release of both superoxide and nitric oxide and is therefore likely to be dependent on reactive nitrogen species. This mechanism, however, is not re¯ected by 3-nitrotyrosine formation in the airways.
Introduction
Asthma is a disease characterized by airway in¯ammation and hyperresponsiveness (Guidelines, 1991) . The concentration of nitric oxide in exhaled air is increased in asthmatics and is thought to re¯ect the state of airway in¯ammation (Massaro et al., 1996; Dupont et al., 1998; ten Hacken et al., 1998) . The role of nitric oxide in the airways, however, is ambiguous. Endogenously released nitric oxide is a bronchodilator (Lei et al., 1993; Nijkamp et al., 1993; Folkerts & Nijkamp, 1998) . Nevertheless, high concentrations of nitric oxide putatively leading to reactive nitrogen species via interaction with radical oxygen species have previously been suggested to be important factors in the pathophysiology of allergic airway disease (Muijsers et al., 1997; Van der Vliet et al., 1999) . This is supported by increased 3-nitrotyrosine staining (Saleh et al., 1998) and increased formation of superoxide upon allergen challenge (Calhoun et al., 1992) in human asthmatic airways.
In the present study, we investigated the contribution of the reactive nitrogen intermediate precursors nitric oxide and superoxide on the development of airway hyperresponsiveness and allergic in¯ammation of the airways was investigated in an established mouse model (de Bie et al., 1996; Hessel et al., 1997; Hofstra et al., 1998) . The formation of nitric oxide and superoxide was prevented by the use of selective inhibitors of inducible nitric oxide synthase and NADPH-oxidase respectively (Muijsers et al., 2000) . Furthermore, the airways of allergen challenged mice were immunohistochemically stained for 3-nitrotyrosine.
It is demonstrated that although airway eosinophilia and increased serum IgE is present, the development of airway hyperresponsiveness is reduced by inhibitors of either inducible NOS (1400 W) or NADPH-oxidase (apocynin).
obtained from the breeding colony of the Central Animal Laboratory (Utrecht, The Netherlands). The mice were housed in macrolon cages and were provided with food and water ad libitum.
Immunization protocol
Active sensitization was performed without adjuvant by seven i.p. injections of 10 mg ovalbumin (grade V) in 0.5 ml pyrogen-free saline on 7 alternate days. Three weeks after the last injection, the mice were exposed to an ovalbumin (2 mg ml 71 ) or saline aerosol challenge for 5 min (once daily) on 8 consecutive days. The aerosols were performed in 5 l exposure chambers coupled to a jet nebulizer (particle size 2 ± 3 mm) driven by compressed air at a¯ow rate of 6 l min
71
.
Treatment with apocynin and 1400 W Mice were treated with either 1400 W (10 mg kg 71 ) (Garvey et al., 1997) or apocynin (4 mg kg
) (Salmon et al., 1998) dissolved in 0.25 ml pyrogen-free saline by eight i.p. injections administered just prior to each ovalbumin challenge described in the previous section. Moreover, in a separate experiment mice were treated with apocynin dissolved in the drinking water (Hart 't et al., 1992) (0.16 or 26.6 mg ml
) during the challenge phase (9 days, starting 1 day before the ®rst challenge). Mice received 4 mg kg 71 day 71 apocynin as calculated by measuring the amount of water consumed.
Airway responsiveness
Using barometric whole-body plethysmography (Buxco, Sharon, CT, U.S.A.), responses to inhaled methacholine, in conscious unrestrained mice were measured as described previously (Hamelmann et al., 1997; Hofstra et al., 1998) . As an index of airway responsiveness, increases in enhanced pause (Penh) were measured. Penh data was statistically analysed using univariate repeated measures analysis of variance. Dose response curves to methacholine were analysed as repeated measures. Data were LOG transformed before analysis to equalize variances in all groups.
Serum levels of ovalbumin specific IgE
Directly after the dose response curve with methacholine the mice were injected with an overdose of pentobarbitone (0.5 g kg 71 body weight). Blood samples were obtained from the mice via a cardiac puncture, left at room temperature for 2 h and subsequently centrifuged for 10 min at 14,000 r.p.m. Serum was collected and samples were kept at 7208C until analysis. Ovalbumin speci®c IgE was measured using an ELISA method as described previously (Hessel et al., 1998) . Levels were compared to a pooled standard serum and expressed as arbitrary units (au ml
71
).
Stimulation of thoracic lymph nodes and lung cells in vitro
Cytokine production by antigen-stimulated T cells derived from both thoracic lymph nodes and lung tissue was determined as described previously (Hofstra et al., 1998) . Mice were injected with an overdose of pentobarbitone (0.5 g kg 71 bodyweight). The lungs were lavaged (as described below) and perfused via the right ventricle with 4 ml saline containing 100 u ml 71 heparin to remove any blood and intravascular leukocytes. The thoracic lymph nodes were isolated from the paratracheal and parabronchial regions. The lymph nodes were transferred to cold PBS and gently homogenized on a 70 mm cell strainer (Falcon, Lelystad, The Netherlands) in order to obtain a single cell suspension. The lymph node and lung cell suspensions were washed, resuspended in culture medium (RPMI 1640 containing 10% FCS, 1% glutamax I, 50 mg ml 71 gentamicin and 50 mM b-mercapto-ethanol) and total cell number counted. Cells (viability 495%, 2610 5 lymph node cells per well) were plated in round-bottom 96-well plates (Costar, Badhoevedorp, The Netherlands) in a volume of 200 ml. The cells were cultured for 5 days with ovalbumin (10 mg ml
71
) or medium only. The cells were cultured at 378C with 5% CO 2 in humidi®ed air. Each in vitro stimulation was performed in triplicate. Supernatants were harvested, pooled per stimulation and kept at 7208C until cytokine levels were determined by ELISA. The IFNg, IL-4 and IL-5 ELISAs were performed according to the instructions of the manufacturer (Pharmingen, San Diego, CA, U.S.A.). The detection limits of the ELISAs were 156 pg ml 71 for IFNg, 15.6 pg ml 71 for IL-4 and 31.3 pg ml 71 for IL-5.
Bronchoalveolar lavage
Bronchoalveolar lavage was performed as described previously (Hessel et al., 1997) . In short, the airways of the mice were cannulated and lavaged ®ve times with 1 ml of pyrogen free saline (378C). The total numbers of lavage cells were determined and cells in cytospin preparations were dierentiated (Di-Quick) into mononuclear cells, eosinophils and neutrophils by standard morphology. At least 200 cells were counted per cytospin preparation and the absolute number of each cell type was calculated.
Immunohistochemistry
Lungs were perfused with PBS (378C) via the right ventricle. Subsequently, the lungs were ®lled with a cryo-conservative (1 ml, Tissue-Tek) via the trachea, removed from the thorax, snap frozen and kept at 7808C until use. Transversal, 5 mm thick lung sections at the level of the tracheo-bronchial tree were prepared using a cryostate (Leica, Germany). Sections were ®xated with acetone for 10 min, and washed with TBS for three times. A speci®c protein binding was blocked with 0.1% bovine serum albumin and 20% normal goat serum in TBS, washed and incubated overnight with a polyclonal rabbit antiserum against 3-nitrotyrosine (see Materials for details). Subsequently, the sections were washed and incubated for 1 h with a polyclonal goat alkaline phosphatase conjugated antiserum speci®cally directed against rabbit IgG, after which the sections were again washed and incubated for 20 min with a commercial fast red substrate chromogen solution containing levamisole to block endogenous phosphatase activity. The sections were counterstained with Mayer's Haematoxylin and evaluated. All incubations were done at room temperature. Seven saline and seven ovalbumin challenged mice from two independent experiments were stained.
Data analysis
Unless stated otherwise data are expressed as mean+ s.e.mean and evaluated using an analysis of variance followed by a post-hoc comparison between groups. A probability value P50.05 was considered statistically signi®cant.
Material
Anti-3-nitrotyrosine from Upstate Biotechnology Inc., Control serum: rabbit IgG (Vector, CA, U.S.A. 
Results

Airway responsiveness
Control mice challenged with ovalbumin showed a signi®-cantly increased responsiveness to methacholine (PENH) compared to saline challenged mice (P50.001, n=9; Figure  1A ,B). Treatment with either 1400 W (P50.05, n=9; Figure  1A ) or apocynin (P50.0001, n=9, Figure 1B ) inhibited ovalbumin-induced hyperresponsiveness. Moreover, oral administration of apocynin via the drinking water (p.o., 4 mg kg 71 day
71
) signi®cantly inhibited ovalbumin-induced hyperresponsiveness (P50.05, n=6, Figure 1C , n=6) still inhibited the bronchoconstriction by 38, 30 (P50.05), and 18% in reponse to 12.5, 25 and 50 mg/ml methacholine respectively. Apocynin did not have an eect on the amount of water consumed (data not shown). Thus, ovalbumin-challenged mice show increased airway responsiveness to methacholine compared to saline-challenged mice, which can be inhibited by treatment with either 1400 W or apocynin.
3-Nitrotyrosine staining
Mice repeatedly challenged with ovalbumin showed a clear in®ltration of in¯ammatory cells into the airways. The cells were mainly grouped in patchy cellular in®ltrates, which are located around broncheoli. These cellular in®ltrates were absent in saline challenged animals. 3-Nitrotyrosine staining was clearly present in the airways of all ovalbumin challenged animals ( Figure 2B , n=9) and was absent in all saline challenged animals (Figure 2A, n=9) . 3-Nitrotyrosine staining was mainly concentrated in eosinophils throughout the airways. Positive eosinophils were found around blood vessels and in bronchus-associated lymphoid tissue ( Figure  2B ). Treatment with either apocynin (n=6) or 1400 W (n=4) did not change eosinophil 3-nitrotyrosine staining in the airways ( Figure 2C,D, respectively) .
Bronchoalveolar lavage
The number of cells in the bronchoalveolar lavage¯uid was used as a measure for the in®ltration of cells into the airways. Ovalbumin challenge resulted in an in¯ux of eosinophils into the airway lumen (Table 1) . No eosinophils could be detected in saline challenged mice. Furthermore, the number of neutrophils and mononuclear cells were signi®cantly greater in ovalbumin challenged animals than in saline challenged animals. Treatment with 1400 W and apocynin did not aect the cellular in¯ux induced by ovalbumin (Table 1) . Moreover, Unstimulated lymph node cells produced undetectable levels of IL-4 and IL-5 and very low levels of IFNg. In vivo challenge with ovalbumin followed by in vitro stimulation by ovalbumin signi®cantly and greatly enhanced production of IL-4 and IL-5 compared to unstimulated cells and cells from saline challenged animals ( Table 2) . Treatment of both salineand ovalbumin-challenged animals with either 1400 W or apocynin did not signi®cantly aect the cytokine levels produced by thoracic lymph node cells in vitro (Table 2) . IFNg production was signi®cantly greater by cells from ovalbumin challenged animals than from saline challenged animals. In vitro ovalbumin stimulation did not signi®cantly change IFNg production. Treatment with 1400 W did not alter IFNg release. Furthermore, apocynin treatment slightly inhibited IFNg production by cells from ovalbumin challenged animals that were not stimulated with ovalbumin in vitro, although this dierence was not statistically signi®cant.
Immunoglobulin E
IgE levels were determined in serum samples taken 24 h after the last challenge. Repeated challenge with ovalbumin 
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Reactive nitrogen species and hyperresponsiveness R.B.R. Muijsers et alresulted in increased levels of ovalbumin-speci®c IgE compared to saline challenge (P50.0001) ( Table 1) . Treatment with 1400 W or apocynin did not in¯uence the allergeninduced increase in serum-IgE, although 1400 W treatment slightly enhanced IgE concentrations in ovalbumin-challenged mice (Table 1) .
Discussion
Increasing evidence exists for the involvement of reactive nitrogen species in the pathobiology of in¯ammatory airway disease (Van der Vliet et al., 1999) . Although the formation of reactive nitrogen species during allergic asthma is well-established (Saleh et al., 1998) , little is known about whether and how reactive nitrogen species contribute to the characteristics of asthma, i.e. airway hyperresponsiveness, airway eosinophilia and speci®c IgE production. The present study demonstrates that inhibition of inducible nitric oxide synthase or inhibition of NADPH oxidase prevents allergen-induced hyperresponsiveness but not 3-nitrotyrosine formation, eosinophil in¯ux or IgE production. These data suggest that nitric oxide, superoxide and possibly reactive nitrogen species released in the airways are involved in the development of airway hyperresponsiveness by an as yet unresolved mechanism. 3-Nitrotyrosine formation by eosinophils, however, does not re¯ect this mechanism.
Interestingly, the putative peroxynitrite footprint 3-nitrotyrosine is readily formed by an nitric oxide independent process mediated by myeloperoxidase, with hydrogen peroxide and the nitric oxide metabolite nitrite as substrates (Kettle et al., 1997; Eiserich et al., 1998) . Since only 10 ± 15% of the BAL cells consisted of neutrophils only a small part of the 3-nitrotyrosine staining can be attributed to this cell type. Eosinophil peroxidase is an even stronger promoter of 3-nitrotyrosine formation (Wu et al., 1999) . The fact that 3-nitrotyrosine was mainly present in eosinophils and could not be inhibited by the NOS inhibitor 1400 W strongly suggest that allergen induced 3-nitrotyrosine formation in eosinophils is completely mediated by a NOS independent process. Moreover, eosinophil peroxidase de®cient mice, unlike wild type mice, do not show 3-nitrotyrosine staining in the airways upon allergen challenge, despite the in¯ux of eosinophils (Duguet et al., 2000) . It remains unclear why the NADPH oxidase inhibitor apocynin also failed to inhibit 3-nitrotyrosine formation. This is not likely to be due to insucient dosages, since substantially lower doses than those used in the present study were able to prevent ulcerative skin lesions in rats (Hart 't et al., 1992) . The relevance of eosinophil peroxidase mediated 3-nitrotyrosine formation in the development of airway hyperreactivity is highly disputable, since 1400 W and apocynin inhibited airway hyperresponsiveness but did not aect 3-nitrotyrosine formation. However, reactive nitrogen species may not lead to 3-nitrotyrosine formation in all circumstances. Further, 3-nitrotyrosine residues may be denitrated by enzymatic activity (Kuo et al., 1999) , leaving them undetected or are simply formed in amounts to low to be detected by immunohistochemistry. Moreover, reactive nitrogen species may release other mediators, such as F2-isoprostanes, that are formed during oxidative stress via a cyclo-oxygenase independent pathway (Roberts & Morrow, 2000) . Interestingly, it was recently demonstrated that a strong hyperresponsiveness could be induced by very low amount of 8-epi-PGF 2a administered to the airways of mice in vivo or in vitro (Held et al., 1999; Held & Uhlig, 2000) . Although apocynin and 1400 W did not alter the number of eosinophils, it cannot be excluded that these inhibitors eected the activity and mediator release of the in¯ammatory cells resulting in less oxidative stress. Apocynin irreversibly inhibits the assembly of the NADPH-oxidase complex on the granulocyte membrane (Simons et al., 1990; Stolk et al., 1994) , thereby preventing the formation of superoxide. Moreover, apocynin is a potent inhibitor of not only superoxide but also peroxynitrite formation by murine macrophages in vitro (Muijsers et al., 2000) . Apocynin, injected intraperitoneally or dissolved in the drinking water, inhibits allergen-induced hyperresponsiveness without aecting the number of eosinophils. Recently, comparable results were obtained by Larsen et al. (2000) in mice that overexpress Cu/Zn superoxide dismutase. These animals were protected against allergen-induced tracheal hyperresponsiveness although an increase in the number of eosinophils in the lungs was still observed. Apocynin could have a therapeutic Reactive nitrogen species and hyperresponsiveness R.B.R. Muijsers et al value by limiting the formation of not only reactive oxygen species, but also reactive nitrogen species.
A number of studies report a putative role for nitric oxide as a mediator of T-cell response (Liew, 1995) . Nitric oxide exposure skews the Th 1 /Th 2 balance into the direction of a Th 2 -response (Chang et al., 1997) . Interestingly, iNOS knockout mice show decreased allergic in¯ammation compared to their wild-type littermates (Xiong et al., 1999) , which is suggested to be due to an enhanced production of the Th 1 cytokine IFNg. Nonetheless, the in vivo treatment with 1400 W did not enhance IFNg production by thoracic lymph node cells in vitro and 1400 W did not signi®cantly alter serum IgE or IL-5 production by thoracic lymph node cells. Treatment with 1400 W did slightly, but not signi®cantly, inhibit IL-4 production by thoracic lymph node cells but the physiological relevance is questionable since an IL-4 neutralizing antibody did not aect the asthmatic phenotype in mice (Hessel et al., 1997) .
Controversy exists as to which isoform of nitric oxide synthase is the main source of nitric oxide during allergic airway in¯ammation. Although NOS2 (iNOS) is upregulated in asthmatic airways (Saleh et al., 1998) , the role for this enzyme in animal models of allergic airway in¯ammation remains unclear. Feder et al. (1997) found no increase in NOS2 protein nor mRNA upon allergic challenge in mice. Xiong et al. (1999) reported inhibition of allergic airway in¯ammation in NOS2-knockouts, but unaltered development of airway hyperresponsiveness, whereas de Sanctis et al. (1999) , showed that knocking out the NOS2 gene neither aects allergic in¯ammation nor airway hyperresponsiveness. Interestingly, allergen induced airway hyperresponsiveness is completely abolished in NOS1 (nNOS) knockouts (de Sanctis et al., 1999) . Based on the fact that 1400 W is at least a 200 fold more potent inhibitor of iNOS compared to nNOS (Garvey et al., 1997) , iNOS is put forward as the most likely candidate in our model.
The cellular and molecular mechanisms leading to increased nitric oxide synthesis and reactive nitrogen species formation upon allergen challenge are not exactly known. In asthmatic subjects, iNOS protein is upregulated in the airway epithelium due to transcriptional regulation (Guo et al., 1997; . IFNg is likely to play an important role in the induction of iNOS during asthma, since the cytokine is essential for iNOS expression in human airway epithelial cells in vitro (Punjabi et al., 1994; Robbins et al., 1994) . Furthermore, the concentration of IFNg is increased in the epithelial lining¯uid of asthmatics (Guo et al., 2000) . Interestingly, the development of allergen induced hyperresponsiveness in the murine model described in this study is dependent on IFNg (Hessel et al., 1997) . Therefore, IFNg could also be the cytokine responsible for iNOS induction during allergic airway in¯ammation. A large population of the T-lymphocytes present in the airways after allergen challenge is non-antigen speci®c and release IFNg (Ying et al., 1995) . Indeed, the present data show that thoracic lymph node cells from ovalbumin challenged animals release increased amounts of IFNg independently of in vitro ovalbumin stimulation.
Conclusion
Inhibitors of either iNOS (1400 W) or NADPH oxidase (apocynin) reduce the development of airway hyperresponsiveness without an eect on airway in¯ammation and serum IgE levels. Furthermore, the formation of 3-nitrotyrosine in eosinophils appears to be mediated by eosinophil peroxidase rather than by nitric oxide synthase related processes and does not seem to re¯ect a pathophysiological mechanism leading to airway hyperresponsiveness. Both nitric oxide synthase and NADPH oxidase inhibition prove to be promising therapeutic targets to prevent the development of allergen induced airway hyperresponsiveness. This work was supported by research grant no. 95.28 from The Netherlands Asthma Foundation
